Glaucoma News

It's the latest rage in beauty products. A simple solution that makes your eyelashes grow.

Dr. Lin is Staff Physician, Michael E. DeBakey Veterans Affairs Medical Center, and Assistant Professor of Ophthalmology, Baylor College of Medicine, Houston, Texas.

A BARRY surgery will be the first centre in Wales to pilot a new glaucoma treatment centre.

Eye-care giant Alcon Laboratories is shelving a long-studied drug that initially had been considered promising for treating age-related macular degeneration and glaucoma.

Find out more about Dr. Cary: Dr. Cary Canoun is a double board certified plastic surgeon who has been in practice for 10 years.

Bimatoprost was approved by the U.S. Food and Drug Administration in December 2008, the cosmetic formulation of bimatoprost will be sold as Latisse, originally the drug was prescribed to control Glaucoma, Doctors and patients alike have noticed that eyelash growth is a side effect of bimatoprost.

Inotek Pharmaceuticals today announced positive top-line results from a Phase 1/2 randomized, double-blind, placebo-controlled clinical trial of the Company's lead candidate, INO-8875, in patients with glaucoma.

New ways of diagnosing and treating patients with glaucoma will be piloted in two areas in Wales, Health Minister Edwina Hart announced today.

A growth in the incidence of eye diseases correlated with aging is prompting a rise in investment for technologies to diagnose and treat such disorders.

Dear Dr. Gott:What would cause my eyelids to twitch? I asked my ophthalmologist the last time I visited him for a pressure test for glaucoma.

Community based treatment of the eye disease glaucoma is to be piloted, with the hope of rolling it out across Wales.

Main Category: Eye Health / Blindness Also Included In: Medical Devices / Diagnostics Article Date: 23 Jun 2009 Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, announced today that it has closed a $35 million Series B round and is continuing the rapid development of ...

Transcend Medical Inc. , an ophthalmic device company focused on the treatment of glaucoma, said Monday it raised $35 million in a second round of funding.

GLAUCOMA is one of the most common causes of blindness worldwide yet many are unaware of its causes and symptoms.

Local residents with glaucoma have new options for treating the degenerative eye disease.

The Glaucoma Research Foundation is pleased to announce the addition of Candler Gibson as the organization's new Director of Development.

Mascara is one thing many women over a certain age would never leave home without; it can mean the difference between looking pin-eyed and wide awake.

Many people take an important aspect of their health for granted - their eyesight.

Americans can sleep more peacefully tonight knowing, at long last, there is a cure for skimpy eyelashes.

With the economy in turmoil, patients are more likely than ever to cut corners. Your practice can help them stay on track.